Back to News
Mar 4, 2026 4:01 PM

PharmaCorp Announces Grant of Stock Options

SASKATOON, Saskatchewan, March 04, 2026 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. ("PharmaCorp" or the "Corporation") (TSXV:PCRX) has granted a total of 213,519 options to purchase common ‎shares to directors, officers, employees and consultants of the Corporation, with an exercise price of $0.44 and ‎an expiry date of March 2, 2036, subject to approval of the TSX Venture Exchange.

The Corporation relied on section 5.5(b) of Multilateral Instrument 61-‎‎101 as the exemption from ‎the formal valuation requirements of MI 61-101 in respect of the grant of ‎options to the directors and officers of ‎the Corporation, as the common shares of the Corporation are not ‎listed on a specified market (and ‎the common shares are ...